Guidance for the development of a selective-reporting or cascade-reporting protocol for antibiotics is available from the

A) Centers for Disease Control and Prevention (CDC).
B) Clinical Laboratory and Standards Institute (CLSI).
C) United States Army Medical Research Institute (USAMRIID).
D) Food and Drug Administration (FDA).